摘要
目的:分析头孢西丁钠联合阿奇霉素治疗老年支气管肺炎的疗效。方法:研究选取了我院收治的80例老年支气管炎患者为研究对象,所有患者均为我院在2017年1月~2018年1月期间收治,采用数字随机法将患者分成实验组和常规组,其中常规组采用头孢西丁钠治疗,实验组联合阿奇霉素进行治疗,对比两组患者的治疗效果。结果:实验组患者的治疗有效率为92.5%(37例),不良反应发生率为5%(2例),其各项观察指标与常规组比较存在统计学意义(P<0.05)。结论:头孢西丁钠联合阿奇霉素治疗老年支气管肺炎疗效显著,且药物不良反应较少,值得推广使用。
Objective:To analyze the efficacy of cefoxitin sodium combined with azithromycin in the treatment of bronchial pneumonia in the elderly.Methods:Eighty elderly patients with bronchitis admitted to our hospital were enrolled in the study.All patients were admitted to our hospital from January 2017 to January 2018.Patients were divided into experimental and routine groups by digital randomization.The conventional group was treated with cefoxitin sodium,and the experimental group was treated with azithromycin to compare the therapeutic effects of the two groups.Results:The effective rate of the experimental group was 92.5%(37 cases),and the incidence of adverse reactions was 5%(2 cases).The observation indexes were statistically significant compared with the conventional group(P<0.05).Conclusion:Cefoxitin sodium combined with azithromycin is effective in the treatment of senile bronchopneumonia,and there are few adverse drug reactions,which is worthy of popularization.
作者
许恒桂
XU Heng-gui(Pharmacy department,The Third People's Hospital of Xinghua,Xinghua jiangsu 225700,China)
出处
《国际感染病学(电子版)》
CAS
2018年第3期17-18,共2页
Infection International(Electronic Edition)
关键词
头孢西丁钠
阿奇霉素
老年支气管肺炎
不良反应
cefoxitin sodium
azithromycin
elderly bronchial pneumonia
adverse reactions